Feifei Wang

1.8k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

Feifei Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feifei Wang has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Feifei Wang's work include Ubiquitin and proteasome pathways (5 papers), Epigenetics and DNA Methylation (4 papers) and Geology and Paleoclimatology Research (3 papers). Feifei Wang is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Epigenetics and DNA Methylation (4 papers) and Geology and Paleoclimatology Research (3 papers). Feifei Wang collaborates with scholars based in China, Australia and United States. Feifei Wang's co-authors include Yanqing Ding, Liang Li, Xiaoli Ren, Wenting Liao, Zhicheng Zeng, Jinlong Hu, Fuyao Song, Xiaohui Zhu, Xiao-Liang Lan and Wei Yang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Feifei Wang

29 papers receiving 1.2k citations

Hit Papers

Cancer-derived exosomal miR-25-3p promotes pre-metastatic... 2018 2026 2020 2023 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Wang China 15 878 617 253 171 99 30 1.2k
Jian‐cheng Ding China 16 662 0.8× 341 0.6× 187 0.7× 109 0.6× 78 0.8× 26 914
Xingguo Song China 23 982 1.1× 760 1.2× 219 0.9× 98 0.6× 139 1.4× 59 1.3k
Veronica A. Carroll United Kingdom 15 595 0.7× 530 0.9× 160 0.6× 125 0.7× 158 1.6× 23 1.1k
Naifei Chen China 16 748 0.9× 585 0.9× 411 1.6× 297 1.7× 185 1.9× 54 1.3k
Xuenong Li China 21 1.1k 1.3× 912 1.5× 207 0.8× 141 0.8× 139 1.4× 47 1.4k
Laurence Nieto France 16 799 0.9× 510 0.8× 212 0.8× 151 0.9× 181 1.8× 32 1.2k
Yanbin Kuang China 15 515 0.6× 326 0.5× 248 1.0× 270 1.6× 294 3.0× 24 1.1k
Yongfu Ma China 18 550 0.6× 475 0.8× 150 0.6× 86 0.5× 193 1.9× 44 945
Christophe Badie United Kingdom 25 905 1.0× 568 0.9× 366 1.4× 128 0.7× 453 4.6× 85 1.8k
Ming Zhong China 20 838 1.0× 571 0.9× 382 1.5× 187 1.1× 104 1.1× 56 1.4k

Countries citing papers authored by Feifei Wang

Since Specialization
Citations

This map shows the geographic impact of Feifei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Wang more than expected).

Fields of papers citing papers by Feifei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Wang. The network helps show where Feifei Wang may publish in the future.

Co-authorship network of co-authors of Feifei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Wang. A scholar is included among the top collaborators of Feifei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Wang. Feifei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Feifei, Xinyu Zhang, Jiahui Yang, et al.. (2025). The role of three glucose/lipid composite indices (CHG, TYG, and AIP) in predicting carotid plaque and fatty liver outcomes: a retrospective cohort study. Frontiers in Endocrinology. 16. 1686931–1686931.
2.
Li, Mingzhou, Shasha Song, Hongling Liu, et al.. (2024). PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancer. BMC Medicine. 22(1). 154–154. 5 indexed citations
3.
Zhang, Zhimin, Li Li, Zhihai Wu, et al.. (2024). Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models. Cancer Immunology Immunotherapy. 73(5). 81–81. 2 indexed citations
5.
Wang, Feifei, Dan Zhang, Zhaowen Zhang, et al.. (2022). Overexpression of GSTP1 promotes colorectal cancer cell proliferation, invasion and metastasis by upregulating STAT3. Advances in Clinical and Experimental Medicine. 31(2). 139–149. 15 indexed citations
6.
Zeng, Sisi, et al.. (2022). Endothelial cell-derived S1P promotes migration and stemness by binding with GPR63 in colorectal cancer. Pathology - Research and Practice. 240. 154197–154197. 6 indexed citations
7.
Wang, Wei, Xuecong Zhang, Chengyong Lei, et al.. (2022). Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell‐free DNA. The Journal of Pathology. 259(4). 376–387. 5 indexed citations
8.
Zeng, Zhicheng, Feifei Wang, Xin Peng, et al.. (2022). HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps. Oncogene. 41(29). 3719–3731. 37 indexed citations
9.
Wang, Feifei, et al.. (2021). Comparison of Phototoxicity Sensitivity by the Neutral Red Uptake Method for BALB/c 3T3, HaCaT, and HDFa Cells In Vitro. SHILAP Revista de lepidopterología. 2(2022). 1–7. 2 indexed citations
10.
Lan, Xiao-Liang, Wanming Hu, Wei Wang, et al.. (2021). CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer. Cancer Immunology Immunotherapy. 70(11). 3235–3248. 22 indexed citations
11.
Ren, Xiaoli, Feifei Wang, Zhicheng Zeng, et al.. (2021). Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer. Cell Death and Disease. 12(5). 484–484. 26 indexed citations
12.
Zhu, Xiaohui, Feifei Wang, Li Zhou, et al.. (2020). FBX8 promotes metastatic dormancy of colorectal cancer in liver. Cell Death and Disease. 11(8). 622–622. 22 indexed citations
13.
Wang, Feifei, Xiaohui Zhu, Kun Zhou, et al.. (2019). FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression. Cell Death and Disease. 10(5). 351–351. 29 indexed citations
14.
Zeng, Zhicheng, Yuling Li, Xiao-Liang Lan, et al.. (2018). Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nature Communications. 9(1). 5395–5395. 738 indexed citations breakdown →
16.
Wang, Feifei, Yi Wang, Xiaohui Zhu, et al.. (2015). Significance of FBX8 in progression of gastric cancer. Experimental and Molecular Pathology. 98(3). 360–366. 15 indexed citations
17.
Wang, Jianmei, Xiaohui Zhu, Jinlong Hu, et al.. (2015). The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer. Oncotarget. 6(29). 27427–27439. 32 indexed citations
18.
Wang, Feifei, Lin Wang, & Jihong Pan. (2014). PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells. Molecular Medicine Reports. 11(1). 698–704. 14 indexed citations
19.
Wang, Feifei, Jiang Yu, Xiaoli Ren, et al.. (2013). FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma. PLoS ONE. 8(6). e65495–e65495. 18 indexed citations
20.
Lv, Zhenbing, Kaiwen Peng, Jianmei Wang, et al.. (2013). The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma. PLoS ONE. 8(10). e77473–e77473. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026